Quantcast

Latest Vaccination Stories

2014-09-09 08:32:26

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Human Vaccine Technologies Market" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Immunization is one of the highest impact and most cost effective methods of preventing infectious diseases, particularly in low and middle income countries with minimal healthcare facilities in remote locations. Many vaccines technologies that could aid improved safety, efficacy and...

2014-09-09 08:30:50

New patent includes composition of matter claims PRINCETON, N.J., Sept. 9, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the US Patent and Trademark Office (US PTO) granted patent 8,808,710 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine...

2014-09-08 16:25:31

The Encore at Wynn Las Vegas: September 11th, 2014 ZUG, Switzerland and NEW YORK, Sept. 8, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various indications in cancer and the central nervous system (CNS), including orphan indications, today announced that Dr. Angelos M. Stergiou, Chief Executive Officer and Chairman of the Board of SELLAS, will...

2014-09-08 16:25:02

Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination SWIFTWATER, Pa., Sept. 8, 2014 /PRNewswire-USNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) approved use of Menactra(®) [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal...

2014-09-08 08:29:28

Presentation to be Webcast Live, 1:15 PM EDT, September 9th PRINCETON, N.J., Sept. 8, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will give a corporate presentation at the 16(th) Annual Rodman & Renshaw Global...

2014-09-06 23:01:05

Global Animal Vaccines Market 2014-2018 and Global Animal Health Market 2014-2018 are new research reports added to Sandlerresearch.org store. Dallas, Texas (PRWEB) September 06, 2014 One of the major emerging trends in this market is an increase in acquisitions. Vendors have been focusing on acquisitions to increase their foothold in the market through increased investments. According to the “Global Animal Vaccines Market 2014-2018” report, one of the main drivers of this market is...

2014-09-05 20:21:03

Horses with melanoma are the subject of this major clinical study TAMPA, Fla., Sept. 5, 2014 /PRNewswire/ -- Morphogenesis Inc., the biotechnology firm developing ImmuneFx(TM), a cancer vaccine that has improved the longevity and quality of life for dogs, cats and horses, announces that a formal equine clinical trial for the direct injection form of the vaccine will begin later this month at a large equine facility in Missouri. Pat Lawman, PhD., co-founder and CEO of Morphogenesis...

2014-09-04 16:27:07

Unique Multivalent WT1 Vaccine to be developed across hematological malignancies and solid tumors NEW YORK, Sept. 4, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company today announced that it has signed an exclusive global collaboration and license agreement with Memorial Sloan Kettering Cancer Center (MSK) for the development, marketing, and commercialization of MSK's proprietary WT1 cancer vaccine. "This...

2014-09-03 12:31:10

Encouraging conversation through valueofvaccination.org WASHINGTON, Sept. 3, 2014 /PRNewswire-USNewswire/ -- An ever-growing body of individuals and organizations has come together for the purpose of highlighting that which is well-known but seldom stated: vaccination adds value to our lives. Building upon a groundswell of public support for vaccination, the Value of Vaccination movement is garnering attention to the benefits that vaccines bring to every community. The initiative...

2014-09-02 12:29:15

Don't wait for October when Back-to-School is best time for flu shots GRAND RAPIDS, Mich., Sept. 2, 2014 /PRNewswire/ -- Meijer pharmacists are playing myth busters and reminding parents why getting flu shots before kids go back to school is the perfect time to minimize the spread of seasonal influenza for families. While the Grand Rapids, Mich.-based retailer anticipates administering 30 percent more flu shots this season than last, Meijer Drug Store Vice President Nat Love says that one of...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'